» Articles » PMID: 38515990

Globus Pallidus Lesion With Iron Deposition and Dopaminergic Denervation in a Patient With a Pathogenic Variant: A Case Report

Overview
Journal Neurol Genet
Date 2024 Mar 22
PMID 38515990
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: -related disorders encompass heterogeneous neuropsychiatric manifestations through GABAergic dysregulation, without any specific abnormalities on brain MRI, nor evidence of dopaminergic cell loss on I-FP-β-CIT SPECT. We report here a case of globus pallidus lesions and dopaminergic denervation in a patient with a pathogenic variant.

Methods: A 26-year-old female patient with intellectual disability, behavioral, and psychiatric disorders treated by neuroleptics for many years developed a parkinsonian syndrome associated with mild hand dystonia and chorea. A 3T brain MRI and I-FP-β-CIT SPECT were performed.

Results: MRI of the brain found bilateral pallidal lesions consistent with neurodegeneration with iron accumulation. The I-FP-β-CIT SPECT showed bilateral striatal presynaptic dopaminergic denervation. Whole-genome sequencing revealed a pathogenic de novo variant. No additional variant was found in any of the genes responsible for Neurodegeneration with Brain Iron Accumulation (NBIA).

Discussion: This is a description of dopaminergic denervation and globus pallidus lesions with iron accumulation related to a pathogenic variant. These findings expand the phenotype of -related disorder and suggest that it could be considered as a differential diagnosis of NBIA.

References
1.
Goodspeed K, Perez-Palma E, Iqbal S, Cooper D, Scimemi A, Johannesen K . Current knowledge of SLC6A1-related neurodevelopmental disorders. Brain Commun. 2020; 2(2):fcaa170. PMC: 7677605. DOI: 10.1093/braincomms/fcaa170. View

2.
Carvill G, McMahon J, Schneider A, Zemel M, Myers C, Saykally J . Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures. Am J Hum Genet. 2015; 96(5):808-15. PMC: 4570550. DOI: 10.1016/j.ajhg.2015.02.016. View

3.
Johannesen K, Gardella E, Linnankivi T, Courage C, de Saint Martin A, Lehesjoki A . Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia. 2018; 59(2):389-402. PMC: 5912688. DOI: 10.1111/epi.13986. View

4.
Levi S, Tiranti V . Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition. Pharmaceuticals (Basel). 2019; 12(1). PMC: 6469182. DOI: 10.3390/ph12010027. View

5.
Zhou Y, Danbolt N . GABA and Glutamate Transporters in Brain. Front Endocrinol (Lausanne). 2013; 4:165. PMC: 3822327. DOI: 10.3389/fendo.2013.00165. View